STAT10d
The closest hospital vs. the one people actually deliver at
In today's Morning Rounds newsletter, proposed cuts to cancer research under the Trump administration, a fake CDC page with ...
Long Island's dangerous roads: Newsday investigates - Newsday
Long Island lost at least 5,800 years of life to fatal crashes in 2023. A yearlong investigative series examines our ...
STAT6d
Vaccine critic’s apparent selection to head HHS autism study shocks experts
The apparent choice of a major player in the anti-vaccine community to conduct an HHS study on autism has shocked vaccine ...
Dhani Harrison on the making of Living in the Material World – and George’s slide style
If All Things Must Pass was Harrison in minor key, Material World is the sound of him turning towards the light. His son, ...
Stratford Herald11d
FEATURE: The Bard’s Birds - In praise of the lark...
In the latest in a series looking at Shakespeare’s references to birds, Steve Sutherland has the lark in his sights.
Becker's Hospital Review3d
Johns Hopkins breaks ground on Florida children’s hospital
Baltimore-based Johns Hopkins Medicine broke ground March 27 on a new pediatric hospital in Wesley Chapel, Fla. The 56-bed Johns Hopkins All Children’s Hospital Wesley Chapel will expand access to ...
The Business Journals7d
Johns Hopkins All Children’s to break ground on new Wesley Chapel hospital
Johns Hopkins All Children’s Hospital Southwest aerial rendering Expand to read more Listen to this article 5 min The 112-acre site near Interstate 75 and Overpass Road will house a 56-bed ...
Tiziana Life announces dosing at JHU, part of Phase 2 trial of foralumab
Tiziana Life Sciences (TLSA) announced dosing has commenced at Johns Hopkins University, JHU, Autoimmunity Center of Excellence, the third ...
Bayfront emergency department quadruples size of ambulance bay
The opening of a new ambulance bay on Friday leaves the 480-bed hospital better equipped to respond during disasters. The ...
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...